Xtant Medical Holdings (XTNT) EBITDA Margin Growth (3y) (2013 - 2025)
Xtant Medical Holdings (XTNT) EBITDA Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 244.00 |
| 10 | Xtant Medical Holdings | 46.30 Mn | 28.69 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,078.00 |
| Jun 30, 2025 | 2,157.00 |
| Mar 31, 2025 | 1,737.00 |
| Dec 31, 2024 | 761.00 |
| Sep 30, 2024 | -303.00 |
| Jun 30, 2024 | -656.00 |
| Mar 31, 2024 | -1,241.00 |
| Dec 31, 2023 | -1,525.00 |
| Sep 30, 2023 | -1,895.00 |
| Jun 30, 2023 | -320.00 |
| Mar 31, 2023 | 47.00 |
| Dec 31, 2022 | -942.00 |
| Sep 30, 2022 | -865.00 |
| Jun 30, 2022 | -482.00 |
| Mar 31, 2022 | -1,015.00 |
| Dec 31, 2021 | 28,608.00 |
| Sep 30, 2021 | -218.00 |
| Jun 30, 2021 | 884.00 |
| Mar 31, 2021 | 925.00 |
| Dec 31, 2020 | 8,987.00 |